03-Nov-2026 15:59:12
HIKALGeneral news
HIKAL LTD : Q2 FY27 EARNINGS RELEASE
• Revenue recorded at ₹434 Cr. • EBITDA stood at ₹45 Cr. • PAT stood at ₹(6) Cr. • Consolidated revenue split: Pharmaceuticals ₹278 Cr (64%), Crop-Protection ₹156 Cr (36%). Impact: FY27 Q2 results showed a revenue of ₹434 Cr.
Hikal Ltd
Open attachment